In the article entitled, “α2-Adrenoreceptor Agonists Are
Neuroprotective in a Rat Model of Optic Nerve Degeneration” by Yoles
et al. (IOVS 40(1):65–73, January 1999), an error was
unintentionally made in the coding of the proprietary interest
designation. The category should be “C5” for EY/MS and “E” for
LW rather than “N.” The authors recognize the importance of the
ARVO Commercial Relationships Policy as a mechanism for ensuring that
the readers have complete information to assist them in assessing the
research being reported and apologize for this regrettable error.